tetradecanoylphorbol acetate has been researched along with camptothecin in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.35) | 18.7374 |
| 1990's | 13 (56.52) | 18.2507 |
| 2000's | 5 (21.74) | 29.6817 |
| 2010's | 4 (17.39) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Huang, HL; Huang, RL; Huang, YL; Lin, TW | 1 |
| Cotter, TG; Glynn, JM; Green, DR; Lennon, SV | 1 |
| Coffee, KA; Cook, JA; Geisel, J; Halushka, PV; Wise, WC | 1 |
| Cross, SM; Gorsky, LD; Morin, MJ | 1 |
| Bertrand, R; Jenkins, J; Pommier, Y; Solary, E | 1 |
| Filloux, C; Frödin, M; Prentki, M; Roche, E; Sekine, N; Van Obberghen, E; Wollheim, CB | 1 |
| DeJesus, A; Giovanella, BC; Kufe, D; Mendoza, JT; Pantazis, P; Rubin, E | 1 |
| Nakabayashi, T; Samuels, DS; Shimizu, N; Shimizu, Y | 1 |
| Bertrand, R; Kohn, KW; Pommier, Y; Solary, E | 1 |
| Chen, G; Davis, AW; Gao, XM; Hua, DH; Newell, SW; Perchellet, EM; Perchellet, JP | 1 |
| Davis, AW; Gao, XM; Hua, DH; Newell, SW; Perchellet, EM; Perchellet, JP | 1 |
| Aggarwal, BB; Mendoza, J; Pantazis, P; Raju, U; Singh, S | 1 |
| Ikuta, K; Itaya, A; Kameoka, M; Ota, K; Tanaka, Y; Yoshihara, K | 1 |
| He, QY; Meng, FH; Xue, SB; Zhang, HQ | 1 |
| Ishiura, S; Koriyama, H; Kouchi, Z; Momoi, T; Saido, TC; Suzuki, K; Umeda, T | 1 |
| Heldebrant, MP; Kaufmann, SH; Meng, XW | 1 |
| Baier, G; Baier-Bitterlich, G; Boecklinger, K; Enzinger, C; Jenny, M; Lutz, C; Nimpf, J; Utermann, G | 1 |
| Arenz, A; Baumstark-Khan, C; Bogner, S; Hellweg, CE; Schmitz, C | 1 |
| Denning, G; Doering, CB; Johnston, JM; Le Doux, JM; Moot, R; Shields, J; Spencer, HT; Whitehead, D | 1 |
| Chang, WY; Choi, YH; Hyun, JW; Jayasooriya, RG; Kim, GY; Park, SR | 1 |
23 other study(ies) available for tetradecanoylphorbol acetate and camptothecin
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Atractylodes; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Lactones; Leukemia; Molecular Structure; Sesquiterpenes; Structure-Activity Relationship | 2016 |
Microfilament-disrupting agents prevent the formation of apoptotic bodies in tumor cells undergoing apoptosis.
Topics: Actin Cytoskeleton; Aphidicolin; Camptothecin; Cell Death; Cell Line; Cell Survival; Cytochalasin B; Humans; Ionomycin; Kinetics; Leukemia; Tetradecanoylphorbol Acetate; Ultraviolet Rays | 1992 |
Endotoxin-induced arachidonic acid metabolism requires de novo protein synthesis and protein kinase C activation.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Animals; Arachidonic Acid; Arachidonic Acids; Bacterial Toxins; Calcimycin; Camptothecin; Cell Survival; Cells, Cultured; Cycloheximide; Dactinomycin; Endotoxins; Enterotoxins; Enzyme Activation; Isoquinolines; Macrophages; Male; Piperazines; Protein Biosynthesis; Protein Kinase C; Rats; Staurosporine; Tetradecanoylphorbol Acetate; Thromboxane B2 | 1991 |
Rapid increase in the activity of DNA topoisomerase I, but not topoisomerase II, in HL-60 promyelocytic leukemia cells treated with a phorbol diester.
Topics: Camptothecin; Cell Line; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Enzyme Activation; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Protein Kinase C; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1989 |
Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Aminoquinolines; Aphidicolin; Apoptosis; Benzamides; Calcium; Calmodulin; Camptothecin; Cell Cycle; Chromatin; Cyclosporine; DNA; Egtazic Acid; Ethers, Cyclic; Humans; Isoquinolines; Leukemia, Experimental; Leukemia, Promyelocytic, Acute; Microscopy, Electron; Naphthalenes; Okadaic Acid; Phosphoprotein Phosphatases; Piperazines; Poly Adenosine Diphosphate Ribose; Poly(ADP-ribose) Polymerase Inhibitors; Polycyclic Compounds; Protein Kinase C; Spermine; Staurosporine; Teniposide; Tetradecanoylphorbol Acetate; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Zinc | 1993 |
Glucose, other secretagogues, and nerve growth factor stimulate mitogen-activated protein kinase in the insulin-secreting beta-cell line, INS-1.
Topics: Calcium; Camptothecin; Cell Line; Cytosol; DNA; Enzyme Activation; Gene Expression Regulation; Genes, Immediate-Early; Glucose; Insulin; Insulin Secretion; Islets of Langerhans; Nerve Growth Factors; Potassium Chloride; Protein Kinases; Tetradecanoylphorbol Acetate | 1995 |
Partial characterization of human leukemia U-937 cell sublines resistant to 9-nitrocamptothecin.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Adhesion; Cell Differentiation; Cell Division; DNA Topoisomerases, Type I; DNA, Neoplasm; Drug Resistance; Flow Cytometry; Humans; Leukemia; Male; Mice; Mice, Nude; Monocytes; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1994 |
Phosphorylation of DNA topoisomerase I is increased during the response of mammalian cells to mitogenic stimuli.
Topics: 3T3 Cells; Animals; Camptothecin; Cell Division; DNA; DNA Topoisomerases, Type I; Growth Substances; Mice; Mitogens; Phosphorylation; Tetradecanoylphorbol Acetate; Transcription, Genetic | 1994 |
Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors.
Topics: Amsacrine; Apoptosis; Camptothecin; Cell Differentiation; DNA; DNA Damage; Etoposide; Humans; Leukemia, Promyelocytic, Acute; Tetradecanoylphorbol Acetate; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tretinoin; Tumor Cells, Cultured | 1993 |
Camptothecin post-treatments inhibit the biochemical events linked to the tumor-promoting component of carcinogenesis in mouse epidermis in vivo.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Camptothecin; DNA; DNA Adducts; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Induction; Enzyme Inhibitors; Epidermis; Female; Mice; Ornithine Decarboxylase; Skin Neoplasms; Structure-Activity Relationship; Tetradecanoylphorbol Acetate; Topoisomerase I Inhibitors | 1996 |
Characterization of the antitumor-promoting activity of camptothecin in SENCAR mouse skin.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Diterpenes; DNA Replication; Female; Mice; Skin Neoplasms; Terpenes; Tetradecanoylphorbol Acetate; Topoisomerase I Inhibitors | 1996 |
Acquisition of cellular resistance to 9-nitro-camptothecin correlates with suppression of transcription factor NF-kappa B activation and potentiation of cytotoxicity by tumor necrosis factor in human histiocytic lymphoma U-937 cells.
Topics: Antineoplastic Agents; Camptothecin; DNA-Binding Proteins; Drug Resistance, Neoplasm; Host Cell Factor C1; Humans; Hydrogen Peroxide; I-kappa B Proteins; Interleukin-1; Lymphoma, Large B-Cell, Diffuse; NF-kappa B; Octamer Transcription Factor-1; Receptors, Tumor Necrosis Factor; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Transcription Factors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1998 |
Establishment of persistent infection with HIV-1 abrogates the caspase-3-dependent apoptotic signaling pathway in U937 cells.
Topics: Apoptosis; Camptothecin; Caspase 3; Caspase Inhibitors; Caspases; DNA Damage; Drug Resistance; HIV-1; Humans; Immunoblotting; Nucleic Acid Synthesis Inhibitors; Protease Inhibitors; Signal Transduction; Teniposide; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha; U937 Cells; Virus Latency | 1999 |
Inhibition of harringtonine-induced apoptosis by tetradecanoylphorbol acetate in human leukemia HL-60 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Carcinogens; Gene Expression Regulation; Genes, myc; Harringtonines; HL-60 Cells; Humans; Tetradecanoylphorbol Acetate | 1997 |
Proteolytic activation of protein kinase C delta and epsilon by caspase-3 in U937 cells during chemotherapeutic agent-induced apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Camptothecin; Caspase 3; Caspase Inhibitors; Caspases; Cysteine Proteinase Inhibitors; Cytarabine; Enzyme Activation; Etoposide; fas Receptor; Humans; Isoenzymes; Oligopeptides; Protein Kinase C; Protein Kinase C-delta; Protein Kinase C-epsilon; Tetradecanoylphorbol Acetate; U937 Cells | 1999 |
Phorbol 12-myristate 13-acetate inhibits death receptor-mediated apoptosis in Jurkat cells by disrupting recruitment of Fas-associated polypeptide with death domain.
Topics: Adaptor Proteins, Signal Transducing; Antigens, CD; Apoptosis; Apoptosis Regulatory Proteins; Binding Sites; Camptothecin; Carrier Proteins; Cell Line; Cycloheximide; Etoposide; fas Receptor; Fas-Associated Death Domain Protein; Gamma Rays; HSP90 Heat-Shock Proteins; Humans; Jurkat Cells; Kinetics; Membrane Glycoproteins; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Tetradecanoylphorbol Acetate; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2002 |
Evidence of functional modulation of the MEKK/JNK/cJun signaling cascade by the low density lipoprotein receptor-related protein (LRP).
Topics: alpha-Macroglobulins; Animals; Camptothecin; Cerebellum; DNA Primers; DNA-Binding Proteins; Enhancer Elements, Genetic; Genes, Reporter; Humans; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; Kinetics; LDL-Receptor Related Protein-Associated Protein; MAP Kinase Kinase Kinase 1; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Nerve Growth Factor; PC12 Cells; Polymerase Chain Reaction; Promoter Regions, Genetic; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-jun; rac1 GTP-Binding Protein; Rats; Recombinant Proteins; Saccharomyces cerevisiae Proteins; Tetradecanoylphorbol Acetate; Transcription Factors; Transcriptional Activation; Transfection | 2002 |
Activation of nuclear factor kappa B by different agents: influence of culture conditions in a cell-based assay.
Topics: Camptothecin; Carcinogens; Cell Culture Techniques; Cell Line; Culture Media, Conditioned; Enzyme Inhibitors; Humans; Interleukin-1beta; Lipopolysaccharides; NF-kappa B; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2006 |
High-throughput screening identifies compounds that enhance lentiviral transduction.
Topics: Animals; Antigens, CD34; Camptothecin; Cell Line, Tumor; Colforsin; Genetic Therapy; Genetic Vectors; Green Fluorescent Proteins; HEK293 Cells; Hematopoietic Stem Cells; High-Throughput Screening Assays; Humans; Lentivirus; Mice; NIH 3T3 Cells; Sirolimus; Tetradecanoylphorbol Acetate; Transduction, Genetic; U937 Cells | 2014 |
Camptothecin suppresses expression of matrix metalloproteinase-9 and vascular endothelial growth factor in DU145 cells through PI3K/Akt-mediated inhibition of NF-κB activity and Nrf2-dependent induction of HO-1 expression.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Heme Oxygenase-1; Humans; Male; Matrix Metalloproteinase 9; NF-kappa B; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; Tetradecanoylphorbol Acetate; Vascular Endothelial Growth Factor A | 2015 |